HCPCS Modifier JB

Description
Administered subcutaneously.

Guidelines/Instructions
  • This modifier is informational only and may be submitted with all injection codes
  • All providers that submit claims for injections of erythropoiesis stimulating agents (ESA) for ESRD beneficiaries are encouraged to include HCPCS modifier JA on the claim to indicate an intravenous administration or HCPCS modifier JB to indicate a subcutaneous administration
  • At this time, reporting these modifiers is voluntary

References

Contact Palmetto GBA JM Part B Medicare

Email Part B

Contact a specific JM Part B department

Provider Contact Center: 855-696-0705

TDD: 866-830-3188

Other Palmetto GBA Sites

Palmetto GBA Home

DMEPOS Competitive Bidding Program

Jurisdiction J Part A MAC

Jurisdiction J Part B MAC

Jurisdiction M Part A MAC

Jurisdiction M Part B MAC

Jurisdiction M Home Health and Hospice MAC

MolDX

National Supplier Clearinghouse MAC

PDAC

RRB Specialty MAC Providers

RRB Specialty MAC Beneficiaries

Anonymous

 


spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer